Clinical Trial Update: PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.

View source ↗

Summary

This clinical trial update reports a completed study evaluating a PSMA PET/CT-based multimodal model to predict response to first-line therapy in metastatic hor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hormone-sensitive Prostate Cancer
• Prostate Cancer

Snippet

Sponsor: First Affiliated Hospital of Wenzhou Medical University | Conditions: Metastatic Hormone-Sensitive Prostate Cancer, Prostate Cancer | Status: COMPLETED